Skip to content

Released May 16, 2011, after the close

10-Q filed May 16, 2011, 46 days after period end · 0000950123-11-050942

Q1 2011 · 10-Q
Revenue—
Net Income-$3.84Mno prior Q1 2010 on fileno prior Q4 2010 on file
EPS Diluted-$0.19no prior Q1 2010 on fileno prior Q4 2010 on file
Operating Cash Flow-$3,027,000—
Free Cash Flowderived-$3,067,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q1 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR